Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis?

Lensing AW, Prins MH.

Thromb Haemost. 1999 Dec;82(6):1564-6. No abstract available.

PMID:
10613635
2.

Factors V Leiden and the prothrombin gene mutation: two common genetic defects associated with thrombosis.

Kujovich JL, Goodnight SH.

West J Med. 1998 Jun;168(6):524-5. No abstract available.

3.

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.

Simioni P, Prandoni P, Lensing AW, Manfrin D, Tormene D, Gavasso S, Girolami B, Sardella C, Prins M, Girolami A.

Blood. 2000 Nov 15;96(10):3329-33.

4.

Prevalence of factor V(Q506) and prothrombin 20210 A mutations in an apparently healthy Icelandic population and patients suffering from venous thrombosis.

Olafsson I, Hjaltadóttir S, Onundarson PT, Pórarinsdóttir R, Haraldsdóttir V.

Thromb Haemost. 1998 Mar;79(3):685-6. No abstract available.

PMID:
9531063
5.

Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.

Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I.

Arthritis Rheum. 2004 Apr 15;51(2):177-83.

6.

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR.

Blood. 2000 Oct 1;96(7):2364-8.

7.

[Genetic risk factors of thrombosis].

Emmerich J, Aiach M.

Ann Cardiol Angeiol (Paris). 2002 Jun;51(3):129-34. Review. French.

PMID:
12471642
8.

Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.

Renner W, Köppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H, Wascher TC, Pilger E.

Thromb Res. 2000 Jul 1;99(1):35-9.

PMID:
10904101
9.

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.

Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM.

Br J Haematol. 2000 Dec;111(4):1223-9.

PMID:
11167765
10.

Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.

González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J.

Blood Coagul Fibrinolysis. 2006 Jan;17(1):23-8.

PMID:
16607075
11.

Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India.

Sharma S, Kumar SI, Poddar U, Yachha SK, Aggarwal R.

Indian J Gastroenterol. 2006 Sep-Oct;25(5):236-9.

PMID:
17090840
12.

Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.

Toydemir PB, Elhan AH, Tükün A, Toydemir R, Gürler A, Tüzüner A, Bökesoy I.

J Rheumatol. 2000 Dec;27(12):2849-54.

PMID:
11128675
13.

Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.

Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY.

Am J Hematol. 2002 Dec;71(4):300-5.

14.

Concurrent factor V Leiden and prothrombin G20210A gene mutations in a patient with a history of recurrent thrombosis.

Mandavilli B, Shoup RM, DiGiuseppe JA, Rezuke WN, Tsongalis GJ.

Conn Med. 2000 May;64(5):259-61.

PMID:
10860231
15.

[Mutation frequencies of the thrombophilic state genes in Uzbekistan].

Sadikova ShE, Karimov KhIa, Muminov ShM, Tulakov RP, Boboev KT.

Tsitol Genet. 2008 Nov-Dec;42(6):50-4. Russian.

PMID:
19253755
16.

Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.

Topaloglu R, Akierli C, Bakkaloglu A, Aydintug O, Ozen S, Besbas N, Ozcelik T.

Clin Rheumatol. 2001;20(4):259-61.

PMID:
11529632
17.

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.

J Natl Cancer Inst. 2006 Jul 5;98(13):904-10.

PMID:
16818854
18.

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W.

Clin Lab Haematol. 2006 Apr;28(2):111-6.

PMID:
16630215
19.

Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.

Kurkowska-Jastrzebska I, Wicha W, Dowzenko A, Vertun-Baranowska B, Pytlewski A, Bogusławska R, Członkowska A.

Med Sci Monit. 2003 May;9(5):CS41-5.

PMID:
12761462
20.

[From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].

Reitsma PH, van de Stolpe A.

Ned Tijdschr Geneeskd. 2001 Sep 22;145(38):1843-5. Review. Dutch.

PMID:
11593787

Supplemental Content

Support Center